Vos HL - Search Results

1

Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension.

Psaty BM, Smith NL, Heckbert SR, Vos HL, Lemaitre RN, Reiner AP, Siscovick DS, Bis J, Lumley T, Longstreth WT Jr, Rosendaal FR. Psaty BM, et al. Among authors: vos hl. JAMA. 2002 Apr 3;287(13):1680-9. doi: 10.1001/jama.287.13.1680. JAMA. 2002. PMID: 11926892

2

Genetic variants of coagulation factor XIII, postmenopausal estrogen therapy, and risk of nonfatal myocardial infarction.

Reiner AP, Heckbert SR, Vos HL, Ariëns RA, Lemaitre RN, Smith NL, Lumley T, Rea TD, Hindorff LA, Schellenbaum GD, Rosendaal FR, Siscovick DS, Psaty BM. Reiner AP, et al. Among authors: vos hl. Blood. 2003 Jul 1;102(1):25-30. doi: 10.1182/blood-2002-07-2308. Epub 2002 Nov 27. Blood. 2003. PMID: 12456499 Free article.

3

Association of the alpha-adducin polymorphism with blood pressure and risk of myocardial infarction.

Psaty BM, Doggen C, Vos HL, Vandenbroucke JP, Rosendaal FR. Psaty BM, et al. Among authors: vos hl. J Hum Hypertens. 2000 Feb;14(2):95-7. doi: 10.1038/sj.jhh.1000943. J Hum Hypertens. 2000. PMID: 10723114

4

Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women.

Psaty BM, Smith NL, Lemaitre RN, Vos HL, Heckbert SR, LaCroix AZ, Rosendaal FR. Psaty BM, et al. Among authors: vos hl. JAMA. 2001 Feb 21;285(7):906-13. doi: 10.1001/jama.285.7.906. JAMA. 2001. PMID: 11180734

5

Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A).

Longstreth WT Jr, Rosendaal FR, Siscovick DS, Vos HL, Schwartz SM, Psaty BM, Raghunathan TE, Koepsell TD, Reitsma PH. Longstreth WT Jr, et al. Among authors: vos hl. Stroke. 1998 Mar;29(3):577-80. doi: 10.1161/01.str.29.3.577. Stroke. 1998. PMID: 9506595

6

A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women.

Rosendaal FR, Siscovick DS, Schwartz SM, Psaty BM, Raghunathan TE, Vos HL. Rosendaal FR, et al. Among authors: vos hl. Blood. 1997 Sep 1;90(5):1747-50. Blood. 1997. PMID: 9292507 Free article.

7

Two factor XIII gene polymorphisms associated with a structural and functional defect and the risk of myocardial infarction in men.

Doggen CJ, Reiner AP, Vos HL, Rosendaal FR. Doggen CJ, et al. Among authors: vos hl. J Thromb Haemost. 2003 Sep;1(9):2056-8. doi: 10.1046/j.1538-7836.2003.00352.x. J Thromb Haemost. 2003. PMID: 12941053 Free article. No abstract available.

8

Haplotypes of the interleukin-1 receptor antagonist gene, interleukin-1 receptor antagonist mRNA levels and the risk of myocardial infarction.

van Minkelen R, Wettinger SB, de Visser MC, Vos HL, Reitsma PH, Rosendaal FR, Bertina RM, Doggen CJ. van Minkelen R, et al. Among authors: vos hl. Atherosclerosis. 2009 Mar;203(1):201-5. doi: 10.1016/j.atherosclerosis.2008.06.029. Epub 2008 Jul 9. Atherosclerosis. 2009. PMID: 18703194

9

The HR2 haplotype of factor V is not associated with the risk of myocardial infarction.

Doggen CJ, de Visser MC, Vos HL, Bertina RM, Cats VM, Rosendaal FR. Doggen CJ, et al. Among authors: vos hl. Thromb Haemost. 2000 Nov;84(5):815-8. Thromb Haemost. 2000. PMID: 11127862

10

A mutation in the thrombomodulin gene, 127G to A coding for Ala25Thr, and the risk of myocardial infarction in men.

Doggen CJ, Kunz G, Rosendaal FR, Lane DA, Vos HL, Stubbs PJ, Manger Cats V, Ireland H. Doggen CJ, et al. Among authors: vos hl. Thromb Haemost. 1998 Nov;80(5):743-8. Thromb Haemost. 1998. PMID: 9843165

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters